Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST CONTENT
Tivozanib Explored in Second-Line ccRCC
Oncologists Weigh BTK/BCL2 Inhibitor Combinations in CLL
Where NALIRIFOX Dose Adjustment Fits in PDAC Care
Walking Through the TIL Therapy Process in Advanced Melanoma
Addition of Lurbinectedin Improves Duration of Maintenance in ES-SCLC
Dose Reduction Is Frequently Employed With Cabozantinib in NETs
Ongoing Trials Could Expand Role of IDH Inhibitors in Resected Glioma
Adjuvant IO Exposure Complicates Treatment Selection for mRCC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement